Private Placement Transactions: Remix Therapeutics: The company raised $70 million of Series B venture funding from Alexandria Venture Investments, Foresite Capital Management and Atlas Venture on May 17, 2022, putting the company’s pre-money valuation at $150...
Strategy | Financing Highlight Private Placement / Financing Transactions Domain Therapeutics: The company raised EUR 39 million of Series A venture funding in a deal led by Panacea Venture, CTI Life Sciences Fund and 3B Future Health Ventures on May 10, 2022. adMare...
Strategy | Financing Highlight Private Placement / Financing Transactions Hello Heart: The company raised $70.00 million of Series D venture funding in a deal led by Stripes on May 2, 2022, putting the company’s pre-money valuation at $530.00 million. Resolute...
Strategy | Financing Highlight Private Placement / Financing Transactions OMass Therapeutics: The company raised $100 million of Series B venture funding in a deal led by GV, Sanofi Ventures, and Northpond Ventures on April 28, 2022. Oxford Spin-out Equity Management,...
Strategy | Financing Highlight Private Placement / Financing Transactions Dianthus Therapeutics: The company raised $100 million of venture funding from undisclosed investors on April 19, 2022. The company is a developer of next-generation complement therapeutics...
Strategy | Financing Highlight Private Placement / Financing Transactions Viz.ai: The company raised $100 million of Series D venture funding in a deal co-led by Tiger Global Management and Insight Partners on April 7, 2022, putting the company’s pre-money...
